ReviewThe ocular surface2012

Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).

William Stevenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.